Change the number and more people need the medication...My doctor tried to convince me when my diastolic stayed below 90 and systolic varied alot.
I smiled at him and told him don't forget I am a nurse and the lower the number the better drug companies like it.....beside, of the two, the second number is the most important...its the number of mm of mercury your heart pushes when at rest....I kept a log of my b/p for a month until my next visit. My b/p drops in the summer when I get off my winter butt and work outside...
Plus taking myself off anti-cholesteral pills due to muscle weakness, pain several other side effects....
Don't ever be afraid of asking your doctor specifically why he wants you to take a medication and his rational for it...it will make you a more informed patient and doctors go by literature in medical journals, and sometimes the studies are less than perfect....
One of the reasons doctors and nurses make the worse patients...
By the time I finish asking questions, he usually gives up and says well let's watch it and see how it goes.LOL.
Maybe you had a vitamin D deficiency? Maybe you still do?
Our specific aims were to determine whether low serum 25 (OH) vitamin D (D2 + D3) (<32 ng/mL) was associated with myalgia in statin-treated patients and whether the myalgia could be reversed by vitamin D supplementation while continuing statins. After excluding subjects who took corticosteroids or supplemental vitamin D, serum 25 (OH) D was measured in 621 statin-treated patients, which consisted of 128 patients with myalgia at entry and 493 asymptomatic patients. The 128 myalgic patients had lower mean +/- standard deviation (SD) serum vitamin D than the 493 asymptomatic patients (28.6 +/- 13.2 vs 34.2 +/- 13.8 ng/mL, P < 0.0001), but they did not differ (p > 0.05) by age, body mass index (BMI), type 2 diabetes, or creatine kinase levels. By analysis of variance, which was adjusted for race, sex, and age, the least square mean (+/- standard error [SE]) serum vitamin D was lower in the 128 patients with myalgia than in the 493 asymptomatic patients (28.7 +/- 1.2 vs 34.3 +/- 0.6 ng/mL, P < 0.0001). Serum 25 (OH) D was low in 82 of 128 (64%) patients with myalgia versus 214 of 493 (43%) asymptomatic patients (chi(2) = 17.4, P < 0.0001). Of the 82 vitamin-D-deficient, myalgic patients, while continuing statins, 38 were given vitamin D (50,000 units/week for 12 weeks), with a resultant increase in serum vitamin D from 20.4 +/- 7.3 to 48.2 +/- 17.9 ng/mL (P < 0.0001) and resolution of myalgia in 35 (92%). We speculate that symptomatic myalgia in statin-treated patients with concurrent vitamin D deficiency may reflect a reversible interaction between vitamin D deficiency and statins on skeletal muscle.